Taking Charge of an Overactive Bladder: Urinary Incontinence

Urinary incontinence and overactive bladder are among the most common underserved health conditions in women. FEMAXEEN is both an effective and safe oral option when compared to the potentially serious side effects associated with pharmaceutical products, such as high blood pressure.

DNA Biopharm recommends women who are just beginning to notice urine leakage to try FEMAXEEN as a first option — the sooner you start treating incontinence the sooner you regain your freedom.

Femaxeen, a bladder control formula, has been developed to help women avoid having to rush to the bathroom frequently while helping to maintain a healthy bladder. In a 90-day clinical study in incontinence sufferers, after taking a daily Femaxeen tablet, there was a significant improvement of 75% in the participants’ ability to maintain normal urine flow. In those women originally classified as having severe incontinence, almost 90% reported improvement.